NCT01912547

Thromboelastography During Surgery for Malignant Pleural Mesothelioma

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Brigham and Women's Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to produce a tracing that records kinetic changes in clot formation. This study aims provide a better understanding of the coagulation profile of these patients, and will form the basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.

Detailed description

Thromboelastography can provide more in-depth and quicker analysis of the complex coagulation processes during surgery

Conditions

• Coagulopathy
• Mesothelioma

Interventions

Type	Name	Description
PROCEDURE	Blood draw for TEG analysis	Blood drawn for TEG analysis

Timeline

• Start date: 2013-09-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2013-07-31
• Last updated: 2015-01-30

Locations

1 site across 1 country: United States